Posted in Regulatory Telomir seeks FDA approval for Telomir-1 to treat breast cancer April 1, 2026 Pharmaceutical Business Review The IND includes results from completed toxicology, pharmacology, and manufacturing studies necessary for regulatory assessment. RegulatoryOncologyRead full story